Literature DB >> 25945446

Th1 chemokines in ulcerative colitis.

F Ragusa1.   

Abstract

Many studies have shown that chemokine (C-X-C motif) receptor (CXCR)3 (a chemokine receptor in the CXC family) and its ligand chemokines, monokine induced by interferon (IFN)-γ(MIG), IFN-γ-inducible protein 10 (IP-10) and IFN-inducible T-cell α chemoattractant (I-TAC), are strongly overexpressed in the intestinal mucosa of mice with experimental colitis, and in patients with ulcerative colitis (UC) both in lymphocytes, in macrophages and in epithelial cells. IFN-γ induces CXCR3 and its chemokines expression in epithelial colonic cells; MIG, IP-10 and I-TAC are important for the recruitment of granulocytes and mononuclear cells and thus for the maintenance of inflammation in UC. Serum IP-10 levels reflected UC disease activity, and it may be a marker for the responsiveness of patients to treatments. Recently, a phase II study suggested that an anti-IP-10 antibody, BMS-936557, is a potentially effective therapy for moderately-to-severely active UC.

Entities:  

Keywords:  Anti-IP-10 antibody; CXCR3; IP-10; Ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 25945446     DOI: 10.7417/CT.2015.1835

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  5 in total

1.  A double conundrum: concurrent presentation of Hashimoto's thyroiditis and ulcerative colitis.

Authors:  Gurpreet Singh; Susie Brien; Ellen Taylor
Journal:  BMJ Case Rep       Date:  2016-04-22

2.  Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells.

Authors:  Rhonda M Brand; Beverley A Moore; Ashley Zyhowski; Aaron Siegel; Shikhar Uttam; E Jeffrey Metter; Jarret Engstrom; Randall E Brand; Nabanita Biswas; David C Whitcomb; David G Binion; Marc Schwartz; Ian McGowan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-12-23       Impact factor: 4.052

3.  Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Authors:  Ane Bjerg Christensen; Anders Dige; Johan Vad-Nielsen; Christel R Brinkmann; Mia Bendix; Lars Østergaard; Martin Tolstrup; Ole S Søgaard; Thomas A Rasmussen; Jens Randel Nyengaard; Jørgen Agnholt; Paul W Denton
Journal:  Mediators Inflamm       Date:  2015-12-01       Impact factor: 4.711

4.  Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia.

Authors:  W Eik; S S Marcon; T Krupek; I T S Previdelli; O C N Pereira; M A R C P Silva; R B Bazotte
Journal:  Braz J Med Biol Res       Date:  2016-07-11       Impact factor: 2.590

Review 5.  Emerging therapeutic options in inflammatory bowel disease.

Authors:  Jesus K Yamamoto-Furusho; Norma N Parra-Holguín
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.